SMTL ID : 3v50.1

Complex of SHV S130G mutant beta-lactamase complexed to SA2-13

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.45 Å

Oligo State

monomer

Ligands

1 x SA2: (3R)-4-[(4-CARBOXYBUTANOYL)OXY]-N-[(1E)-3-OXOPROP-1-EN-1-YL]-3-SULFINO-D-VALINE(Covalent)

SA2.1: 14 residues within 4Å: Chain A: M.44, S.45, K.48, D.79, Y.80, G.105, N.107, E.141, T.142, N.145, K.209, T.210, G.211, A.212 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.80 Hydrogen bonds: A:S.45, A:G.105, A:N.107, A:N.145, A:A.212, A:A.212 Water bridges: A:N.145 Salt bridges: A:K.48, A:K.209

2 x MA4: CYCLOHEXYL-HEXYL-BETA-D-MALTOSIDE(Non-covalent)

MA4.2: 12 residues within 4Å: Chain A: I.196, V.199, P.201, I.206, A.222, V.234, I.236, I.252, A.253, A.257, I.260, E.261 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.196, A:I.206, A:A.222, A:V.234, A:I.236, A:I.252 Hydrogen bonds: A:E.261, A:E.261 Water bridges: A:S.1, A:S.1 MA4.3: 4 residues within 4Å: Chain A: T.210, R.218, N.249, I.252 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:T.210, A:I.252

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ke, W. et al., The importance of the trans-enamine intermediate as a beta-lactamase inhibition strategy probed in inhibitor-resistant SHV beta-lactamase variants. Chemmedchem (2012)

Release Date

2012-08-08

Peptides

Beta-lactamase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Beta-lactamase

Related Entries With Identical Sequence